search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Genetic immunological causes of recurrent miscarriages; 'HLA sharing as a cause of recurrent miscarriages'.


- candidate number12257
- NTR NumberNTR3402
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR18-apr-2012
- Secondary IDs 
- Public TitleGenetic immunological causes of recurrent miscarriages; 'HLA sharing as a cause of recurrent miscarriages'.
- Scientific TitleGenetic immunological causes of recurrent miscarriages; 'HLA sharing as a cause of recurrent miscarriages'.
- ACRONYM
- hypothesisRecurrent miscarriages is defined as three or more consecutive miscarriages prior to the 20th week of gestation. Whenever the diagnosis ‘recurrent miscarriages’ is established, an underlying cause may be identified in about 25-50% of cases. A successful implantation of the embryo needs an adequate maternal immune response; an inadequate maternal allo-immune response to paternal antigens has been proposed to be responsible for a proportion of these unexplained miscarriages. In the case of shared human leukocyte antigens (HLA) in couples a depressed response of maternal PBMCs may occur and as a consequence of this a failure of placentation can take place.
Therefore, the influence of HLA-sharing in couples with unexplained recurrent miscarriages has been studied extensively. However it is still unclear whether the HLA antigens themselves are the susceptibility factors or whether they are linked to other genes that are the main causative agents for the onset of recurrent miscarriages. Also influences of different KIR (NK inhibitory receptors) haplotypes, polymorphism in hPR (Human Progesteron Receptor) receptor and mutations in complement regulatory proteins remains unclear. We hypothezised that genetically factors such as HLA sharing could be responsible for recurrent miscarriages of unknown etiology.
- Healt Condition(s) or Problem(s) studiedRecurrent miscarriages
- Inclusion criteriaRecurrent miscarriages (>2 and < 20 weeks) and age < 36 years.
- Exclusion criteriaParental chromosomal abnormalities and uterus anomalies.
- mec approval receivedno
- multicenter trialno
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 1-jun-2012
- planned closingdate1-jun-2013
- Target number of participants432
- InterventionsPeripheral bloodsamples from patient and partner will be obtained only once, also after informed consent buccal swabs from their children will be taken.
- Primary outcomeDifference genetic profile patients and controls (HLA (mis)matches, frequency HLA-C2, frequency KIRAA, polymorphism hPR, mutations of complement regulatory proteins).
- Secondary outcomePregnancy outcome.
- TimepointsPatients, partners and their children will be invited to visit the clinic once for filling in questionnaire and donating bloodsamples.
We will invite all couples at the same day. After this we will analyze questionnaires and perform genotyping this will cost us approximately 3-6 months.
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIESDr. K.W.M. Bloemenkamp
- CONTACT for SCIENTIFIC QUERIESDr. K.W.M. Bloemenkamp
- Sponsor/Initiator Leiden University Medical Center (LUMC), Department of Obstetrics
- Funding
(Source(s) of Monetary or Material Support)
Leiden University Medical Centre, Department IHB and Department of Obstetrics
- PublicationsN/A
- Brief summaryRecurrent miscarriages is commonly defined as three or more consecutive miscarriages prior to the 20th week. It is a common problem affecting 1 to 2% of all fertile couples and is a highly heterogeneous condition. An underlying cause may be identified in about 25-50% of cases. Therefore 50-75% of the couples are left with the burden of continuous uncertainty and clinicians without means to treat these women. In the last decade several therapies were investigated, however none of these therapies have been proven effective. In this project we aim to determine different genetic immunological causes of recurrent miscarriage of unknown etiology. These results will help to identify these patients and to eventually develop effective therapies.
- Main changes (audit trail)
- RECORD18-apr-2012 - 30-apr-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl